XML 16 R8.htm IDEA: XBRL DOCUMENT

LIQUIDITY	9 Months Ended
Sep. 30, 2022
LIQUIDITY
Liquidity	NOTE 2 - LIQUIDITY: At September 30, 2022 and December 31, 2021, the Company had cash and cash equivalents of $451,693 and $497,135, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the nine months ended September 30, 2022 and 2021, amounted to $45,442 and $1,506,131, respectively, and we had working capital of approximately $451,216 and $496,658 at September 30, 2022 and December 31, 2021, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

LIQUIDITY

9 Months Ended

Sep. 30, 2022

NOTE 2 - LIQUIDITY:

At September 30, 2022 and December 31, 2021, the Company had cash and cash equivalents of $451,693 and $497,135, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the nine months ended September 30, 2022 and 2021, amounted to $45,442 and $1,506,131, respectively, and we had working capital of approximately $451,216 and $496,658 at September 30, 2022 and December 31, 2021, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.